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Abstract
Eukaryotic cells synthesize sterols in the endoplasmatic reticulum (ER) from where it needs to be efﬁciently transported to the plasma mem-
brane, which harbors w90% of the free sterol pool of the cell. Sterols that are being taken up from the environment, on the other hand, are
transported back from the plasma membrane to the ER, where the free sterols are esteriﬁed to steryl esters. The molecular mechanisms that
govern this bidirectional movement of sterols between the ER and the plasma membrane of eukaryotic cells are only poorly understood. Proper
control of this transport is important for normal cell function and development as indicated by fatal human pathologies such as Niemann Pick
type C disease and atherosclerosis, which are characterized by an over-accumulation of free sterols within endosomal membranes and the ER,
respectively. Recently, a number of complementary approaches using Saccharomyces cerevisiae as a model organism lead to a more precise
characterization of the pathways that control the subcellular transport of sterols and led to the identiﬁcation of components that directly or
indirectly affect sterol uptake at the plasma membrane and its transport back to the ER. A genetic approach that is based on the fact that yeast
is a facultative anaerobic organism, which becomes auxotrophic for sterols in the absence of oxygen, resulted in the identiﬁcation of 17 genes
that are required for efﬁcient uptake and/or transport of sterols. Unexpectedly, many of these genes are required for mitochondrial functions. A
possible connection between mitochondrial biogenesis and sterol biosynthesis and uptake will be discussed in light of the fact that cholesterol
transport into the inner membranes of mitochondria is a well established sterol transport route in vertebrates, where it is required to convert
cholesterol into pregnenolone, the precursor of steroids.
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1. Introduction
Sterols are a major lipid component of the plasma mem-
brane of eukaryotic cells, where they have been proposed to
maintain a vital electrochemical gradient across the plasma
membrane [1]. In addition, sterols determine other important
membrane characteristics that appear to be more transient
and are required for polar sorting events during vesicle trans-
port in animal, plant, and fungal cells.
Due to the importance of cholesterol invarious cell functions,
the levels and intracellular distribution of this lipid must be
tightly controlled [2,3]. While the mechanism that coordinates
the de novo synthesis and uptake of cholesterol can now be stud-
ied at the molecular level, much less is known about how the
relative distribution of cholesterol between the various intracel-
lular membranes is controlled [4]. Proper intracellular transport
of cholesterol is essential as indicated by the phenotype of
human diseases that have been associated with sterol transport
defects. Most notably Niemann-Pick type C1 disease, a fatal
neurodegenerative disorder that is characterized by the accumu-
lation of free cholesterol within a late endosomal compartment,
or the atherosclerotic macrophages, where an excess of free
sterol in the ER leads to the induction of apoptosis [5].
Abbreviations: ER, endoplasmatic reticulum; LDL, low-density lipopro-
tein; SREBPs, sterol regulatory element binding proteins.
* Tel.: þ41 26 300 8654; fax: þ41 26 300 9735.
E-mail address: roger.schneiter@unifr.ch
1
Published in "Biochimie 89(2): 255-259, 2007"










Cholesterol is synthesized through a cascade of enzymatic
reactions that are located in the ER and the mature free choles-
terol is subsequently transported to the plasma membrane,
which harbors w90% of the free sterol pool of the cell. This
transport process may involve both vesicular and non-vesicu-
lar components, as indicated by the observation that delivery
of newly synthesized cholesterol to the plasma membrane is
ATP-dependent, but only partially sensitive to disruption of
vesicular transport by brefeldin A [2,3].
Exogenous cholesterol is taken up through receptor-medi-
ated endocytosis of low-density lipoproteins (LDL). Once
delivered to late endosome or lysosome, LDL-derived choles-
teryl esters are hydrolyzed, and free cholesterol is rapidly
cycled back to the plasma membrane and/or the ER for re-
esteriﬁcation. Maintenance of the cycle between free and es-
teriﬁed sterols thus relies on a bidirectional transport of sterols
between the ER and the plasma membrane and/or an endocytic
compartment. This movement of cholesterol from the plasma
membrane to the ER is inhibited by hydrophobic amines,
progesterone, disruption of the cytoskeleton or that of the
acidic compartments, but not by ATP depletion, indicating
that it occurs through a non-vesicular route [2,3].
2. Sterol uptake and transport pathways in yeast
Yeast is a valuable genetic model organism to characterize
basic cellular processes that are conserved in all eukaryotic
cells. S. cerevisiae has been established as a model organism
to study sterol function and biosynthesis by the pioneering
work of Parks and colleagues [6]. The basic steps of sterol
synthesis in yeast are the same as in higher eukaryotic cells,
even though this fungus does not synthesize cholesterol, but
a close structural relative, termed ergosterol [7]. As in mam-
malian cells, ergosterol is synthesized in the ER, from where
it is transported by a poorly characterized mechanism to the
plasma membrane, the major ergosterol containing membrane
in yeast [8]. Recent characterization of the nature of this
forward transport pathway has revealed that the newly synthe-
sized ergosterol equilibrates with a half-time of 10e15 min
with the plasma membrane-localized sterol pool, which
corresponds to the transport of approximately 105 ergosterol
molecules into and out of the plasma membrane per second
[9]. This equilibration is independent of the secretory pathway,
but delayed in mutant cells that have reduced levels of sphin-
golipids [10]. This observation was taken to suggest that the
‘‘chemical activity’’ or concentration of free sterol in the ER
is the same as that of the plasma membrane, but that the
bulk of the plasma membrane sterol is trapped into condensed
complexes with sphingolipids, i.e. within lipid microdomains/
‘‘rafts’’, and thus cannot contribute to the equilibration process
between the two membranes, a concept originally formulated
by McConnell and colleagues [11]. In such a model, transport
of sterols between the two compartments may be facilitated by
soluble lipid carrier proteins and/or close apposition of the
organellar membranes. The proteins that mediate this sterol
transport or those that maintain membrane apposition, how-
ever, remain to be identiﬁed. Recent structural analysis of
a member of the oxysterol-binding protein homologues (Osh
proteins), a family of seven proteins in yeast, all of which
contain a putative sterol-binding domain, suggests a possible
sterol transport cycle in which Osh proteins could act to facil-
itate the equilibration of sterols between different intracellular
membranes [12]. Osh4 binds a single sterol molecule with a Kd
of 300 nM within a hydrophobic tunnel that is covered upon
sterol binding by a ﬂexible lid domain [12]. A role of Osh pro-
teins in sterol transport or the regulation of sterol distribution
is furthermore indicated by the observation that the intracellu-
lar sterol distribution is altered in mutant cells that lack Osh
function [13].
Examination of a requirement of these Osh proteins for
sterol equilibration from the ER to the plasma membrane,
however, revealed only a moderate, ﬁve-fold delay in mutants
lacking Osh function, indicating that Osh proteins may not be
sterol transporters by themselves, but that they affect sterol
transport indirectly, for example by affecting the ability of
the plasma membrane to sequester sterols [9]. The transport
of sterols back from the plasma membrane to the ER, however,
requires Osh function and is greatly reduced in mutants that
fail to synthesize certain phosphoinositide phosphates (PIPs),
indicating that PIPs modulate sterol transfer by the Osh pro-
teins, which is consistent with the presence of a PIP-binding
pleckstrin homology domain in a subset of the Osh proteins
[14]. Whether the Osh proteins indeed act to transport sterols
between different membranes or whether they rather function
as lipid sensors to regulate lipid transport, however, remains to
be established. This discrimination is not a trivial task as
exempliﬁed by another well characterized but still poorly
understood lipid binding protein, Sec14 and its homologues
[15]. Sec14 has originally been identiﬁed as a lipid transfer
protein that exchanges phosphatidylinositol and phosphatidyl-
choline. Subsequent genetic analysis, however, revealed that
Sec14 is required to repress the synthesis of phosphatidylcho-
line in the Golgi apparatus and that phosphatidylinositol-bind-
ing is dispensable for its essential function to promote vesicle
budding from the Golgi complex in vivo [16]. In mammals,
one of the oxysterol-binding proteins acts as cholesterol-bind-
ing scaffolding protein coordinating the activity of two phos-
phatases to control the extracellular signal-regulated kinase
(ERK) pathway [17]. Remarkably, membrane association of
two of the yeast Osh proteins, Osh6 and Osh7, is regulated
by Vps4, a member of an ATPase family of proteins impli-
cated in the disassembly of protein complexes, suggesting
that this class of ATPases may break the interaction of Osh
proteins with their membrane receptors to regulate lipid trans-
port and/or sensing [18].
An excess of free sterol in the ER is buffered by its acyla-
tion with long chain fatty acids, which converts the free sterol
into a steryl ester. Depending on the growth phase, these steryl
esters can reach similar levels as free sterols [19]. In contrast
to free sterols, steryl esters are not membrane forming lipids
but storage lipids that are packed away into intracellular lipid
particles. The acylation of free sterols to steryl esters is
catalyzed by two acyltransferases that are localized in the











membranes could be a means to reduce the ‘‘chemical activ-
ity’’ of the lipid in this membrane and thus regulate the equil-
ibration with the plasma membrane pool. The fact that sterol
acylation is not essential under standard growth conditions,
may indicate that the cell has other means to prevent a poten-
tially harmful accumulation of free sterol in the ER membrane.
Steryl esters are re-converted to free sterols through the action
of a family of three membrane-anchored lipases that hydrolyze
the ester bond to release the free sterol [21]. These lipases
essentially complete the sterol esteriﬁcation and de-esteriﬁca-
tion cycle and their activities are crucial to regulate cellular
levels of free ergosterol under various growth conditions [22].
Saccharomyces cerevisiae does not take up exogenous
sterol in the presence of oxygen, but cells become sterol auxo-
troph in the absence of oxygen or if they are not able to
synthesize heme [23]. The molecular basis for the exclusion
of sterols under aerobic conditions is not well understood,
but it can partially be overcome by expression of a gain-of-
function allele of the transcription factor UPC2 or its homo-
logue ECM22, or by overexpression of the transcriptional
regulator SUT1 [24,25]. Aerobic uptake of sterols in the
UPC2-1mutant is mediated by upregulation of two ABC trans-
porters,PDR11 andAUS1, and a putative cell wall protein, Dan1
[26,27]. Consistent with a role of these two ABC transporters in
sterol uptake, a pdr11D aus1D double mutant does not grow un-
der anaerobic conditions and the double mutant has a greatly re-
duced rate of steryl ester formation from exogenously supplied
sterols [26,28]. Consistent with the proposition that the ‘‘chem-
ical activity’’ of the sterol in the plasmamembrane is reduced by
formation of sterol-sphingolipid complexes, the rate of esteriﬁ-
cation of exogenously supplied sterols is increased for sterols
that have low afﬁnity to form detergent-insoluble domains
[28]. In Schizosaccharomyces pombe, on the other hand, lack
of oxygen results in the induction of the de novo synthesis of
sterols rather than cholesterol auxotrophy as is the case in
S. cerevisiae. Sterol biosynthesis in S. pombe is controlled by
the regulated proteolysis of membrane bound transcription fac-
tors that are orthologous of the mammalian SREBPs (sterol
regulatory element binding proteins) [29]. Sterols control the ac-
tivation of SREPBs by regulating their transport out of the ER
and to the Golgi apparatus, where their membrane attachment
is cleaved by proteases [4]. Interestingly, the SREBP pathway
in S. pombe also controls the expression of genes that are impor-
tant for non-respiratory oxygen consumption and is itself re-
quired for anaerobic growth [29,30]. Evolution of the SREBP-
pathway in S. pombe thus appears to have taken place at the
expense of a sterol uptake pathway.
A defect in sterol uptake and impaired growth under anaer-
obic conditions was also observed in S. cerevisiae cells that
lack ARV1, a gene that is required for viability of cells that
lack steryl esters [31]. ARV1 encodes a conserved protein
with six putative transmembrane domains and localizes
to the ER and Golgi membranes [32]. In addition to their
defect in sterol uptake, arv1D mutants have pleiotropic defects
in sphingolipid, phospholipid and sterol metabolism, but
the precise molecular function of Arv1 remains to be deﬁned
[32].
3. A genetic screen for sterol uptake and transport
mutants
We became interested in sterol trafﬁcking because we
isolated mutants in the sterol biosynthetic pathway as being
synthetic lethal with mutants in fatty acid elongation. Subse-
quent work then showed that the combination of defects in
certain sterol modiﬁcations with defects in sphingolipid syn-
thesis affects the raft association and the stability of integral
membrane proteins, such as the proton pumping ATPase
[33,34]. These observations together with those made by
others (see above) indicate that sterol trafﬁcking is intimately
related to sphingolipid metabolism in yeast and mammalian
cells.
In an ab initio approach to identify genes that are required
for sterol uptake and trafﬁcking in yeast, we screened the yeast
deletion mutant collection for genes that are required for
growth under anaerobic conditions, i.e. conditions under
which yeast is auxotrophic for sterols. Of approximately 37
primary mutants isolated in this screen, 17 affect sterol uptake
and/or trafﬁcking as assessed by genetic and biochemical anal-
yses (see Table 1) [35,36]. When incubated with [14C]-choles-
terol, these mutants fail to take up the label and they show no
or greatly reduced levels of radiolabeled free and esteriﬁed
cholesterol. Furthermore, the sterol transport defect in these
mutants could be visualized by ﬂuorescent microscopy of cells
that had been incubated with NBD-cholesterol, a ﬂuorescent
cholesterol derivative, [37]. In wild-type cells, NBD-choles-
terol displays intense staining of the plasma membrane and
staining of intracellular lipid particles, consistent with our
observation that NBD-cholesterol is esteriﬁed to steryl esters,
which are packaged into intracellular lipid particles [36]. The
sterol uptake mutants, on the other hand, show no or only little
staining of the plasma membrane and intracellular lipid parti-
cles, consistent with a defect in sterol uptake and trafﬁcking
(Fig. 1).
Remarkably, the largest class of mutants isolated in this
screen is affected in mitochondrial functions. This ﬁnding
was unexpected and indicates that at least one as yet uniden-
tiﬁed mitochondrial function is required for uptake of sterols
by yeast under anaerobic conditions. On the other hand,
a screen for mutants that affect mitochondrial morphology
and inheritance recently revealed that ergosterol biosynthesis
is important to maintain mitochondrial morphology even in
the presence of oxygen [38]. This observation together with
the fact that the ergosterol content of cells drops up to four-
fold upon shift to anaerobic conditions could indicate that a re-
duced sterol content in the mitochondrial membrane could
exacerbate an otherwise non-harmful mitochondrial defect,
resulting in a complete loss-of-function of that vital organelle
and a concomitant defect in sterol uptake [39]. On the other
hand, mitochondria themselves are known to be important
for sterol metabolism in vertebrate and insect cells. They har-
bor the cytochrome P450 side chain cleavage enzyme, which
converts cholesterol into pregnenolone, the precursor of ste-
roids [40]. Remarkably, heterologous expression of P450











the conversion of endogenously synthesized sterols to preg-
nenolone, thus indicting that sterols are accessible and thus
transported to the P450 system that is located in the matrix
side of the inner mitochondrial membrane [41]. Transport
routes for sterols either from the ER or the plasma membrane
into mitochondria thus appear to have evolved at some point
and may already be present in yeast, where they may also
be important for sterol uptake under anaerobic conditions.
Taken together, the results of this screen for sterol uptake
and transport mutants in yeast revealed 17 genes that are
required for growth under anaerobic conditions and for the
efﬁcient uptake of cholesterol. Aim of future studies now is
to characterize the sterol trafﬁcking defect of these mutants
in more detail and in particular to understand the role of mito-
chondria in sterol uptake. Results of such studies are likely to
be relevant for a better understanding of the pathology of
human lipid storage diseases and to understand how sterols
are partitioned between the different intracellular membranes.
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